Format

Send to

Choose Destination
See comment in PubMed Commons below
Clin Chest Med. 2012 Jun;33(2):297-305. doi: 10.1016/j.ccm.2012.02.005. Epub 2012 Mar 31.

Diffuse panbronchiolitis.

Author information

1
Japan Anti-Tuberculosis Association, Fukujuji Hospital, Kiyose, Tokyo, Japan. kudous@fukujuji.org

Abstract

Diffuse panbronchiolitis (DPB) is characterized by chronic airway infection with diffuse bilateral micronodular pulmonary lesions. DPB is mainly distributed in east Asian people. Studies on causes of the disease point to a genetic predisposition unique to Asians. The advent of low-dose, long-term macrolide therapy has changed disease prognosis. The mechanism of action is attributed to anti-inflammatory actions of 14-membered and 15-membered ring macrolides. Recently, the success of macrolide therapy in DPB has extended its application to the treatment of other chronic airway inflammatory diseases.

PMID:
22640847
DOI:
10.1016/j.ccm.2012.02.005
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center